The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Tetrahydrobiopterin-dependent preservation of nitric oxide–mediated endothelial function in diabetes by targeted transgenic GTP–cyclohydrolase I overexpression
Open accessAbstract
Increased production of reactive oxygen species and loss of endothelial NO bioactivity are key features of vascular disease states such as diabetes mellitus. Tetrahydrobiopterin (BH4) is a required cofactor for eNOS activity; pharmacologic studies suggest that BH4 may mediate some of the adverse effects of diabetes on eNOS function. We have now investigated the importance and mechanisms of BH4 availability in vivo using a novel transgenic mouse model with endothelial-targeted overexpression of the rate-limiting enzyme in BH4 synthesis, guanosine triphosphate-cyclohydrolase I (GTPCH). Transgenic (GCH-Tg) mice demonstrated selective augmentation of endothelial BH4 levels. In WT mice, induction of diabetes with streptozotocin (STZ) increased vascular oxidative stress, resulting in oxidative loss of BH4, forming BH2 and biopterin. Endothelial cell superoxide production in diabetes was increased, and NO-mediated endothelium-dependent vasodilatation was impaired. In diabetic GCH-Tg mice, superoxide production from the endothelium was markedly reduced compared with that of WT mice, endothelial BH4 levels were maintained despite some oxidative loss of BH4, and NO-mediated vasodilatation was preserved. These findings indicate that BH4 is an important mediator of eNOS regulation in diabetes and is a rational therapeutic target to restore NO-mediated endothelial function in diabetes and other vascular disease states.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Superoxide generation by endothelial nitric oxide synthase: The influence of cofactors
Vásquez-Vivar, J., Kalyanaraman, B., Martásek, P., Hogg, N., Masters, B. S. S., Karoui, H., Tordo, P., & Pritchard, K. A. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.16.9220 · Cited by 1,484
Mechanisms Underlying Endothelial Dysfunction in Diabetes Mellitus
Hink, U., Li, H., Mollnau, H., Oelze, M., Matheis, E., Hartmann, M., Skatchkov, M., Thaiss, F., Stahl, R. A. K., Warnholtz, A., et al. (2001) · Circulation Research · doi:10.1161/01.res.88.2.e14 · Cited by 1,187
Cellular and molecular mechanisms of endothelial cell dysfunction.
Harrison, D. G. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119751 · Cited by 1,053
Mammalian nitric oxide synthases
Stuehr, D. J. (1999) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/s0005-2728(99)00016-x · Cited by 996
Guzik, T. J., Mussa, S., Gastaldi, D., Sadowski, J., Ratnatunga, C., Pillai, R., & Channon, K. M. (2002) · Circulation · doi:10.1161/01.cir.0000012748.58444.08 · Cited by 979
Self-citationTetrahydrobiopterin biosynthesis, regeneration and functions
Thöny, B., Auerbach, G., & Blau, N. (2000) · Biochemical Journal · doi:10.1042/0264-6021:3470001 · Cited by 893
Cosentino, F., Hishikawa, K., Katusic, Z. S., & Lüscher, T. F. (1997) · Circulation · doi:10.1161/01.cir.96.1.25 · Cited by 763
Laursen, J. B., Somers, M., Kurz, S., McCann, L., Warnholtz, A., Freeman, B. A., Tarpey, M., Fukai, T., & Harrison, D. G. (2001) · Circulation · doi:10.1161/01.cir.103.9.1282 · Cited by 721
Tetrahydrobiopterin restores endothelial function in hypercholesterolemia.
Stroes, E., Kastelein, J., Cosentino, F., Erkelens, W., Wever, R., Koomans, H., Lüscher, T., & Rabelink, T. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119131 · Cited by 588
Oxidation of Tetrahydrobiopterin by Peroxynitrite: Implications for Vascular Endothelial Function
Milstien, S., & Katusic, Z. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.1422 · Cited by 486
Schlaeger, T. M., Bartunkova, S., Lawitts, J. A., Teichmann, G., Risau, W., Deutsch, U., & Sato, T. N. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.7.3058 · Cited by 473
Heitzer, T., Krohn, K., Albers, S., & Meinertz, T. (2000) · Diabetologia · doi:10.1007/s001250051551 · Cited by 427
Oxygen Reduction by Nitric-oxide Synthases
Stuehr, D., Pou, S., & Rosen, G. M. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.r100011200 · Cited by 400
Shinozaki, K., Kashiwagi, A., Nishio, Y., Okamura, T., Yoshida, Y., Masada, M., Toda, N., & Kikkawa, R. (1999) · Diabetes · doi:10.2337/diabetes.48.12.2437 · Cited by 329 · cited 1×
“Some features of endothelial dysfunction are improved by high-concentration BH4 supplementation in vessel rings from animals with diabetes (12, 13) or atherosclerosis (14) and Tetrahydrobiopterin-dependent preservation of nitric”
BackgroundRockett, K. A., Brookes, R., Udalova, I., Vidal, V., Hill, A. V. S., & Kwiatkowski, D. (1998) · Infection and Immunity · doi:10.1128/iai.66.11.5314-5321.1998 · Cited by 306
Self-citationVÁSQUEZ-VIVAR, J., MARTÁSEK, P., WHITSETT, J., JOSEPH, J., & KALYANARAMAN, B. (2002) · Biochemical Journal · doi:10.1042/bj3620733 · Cited by 287
Wever, R. M. F., van Dam, T., van Rijn, H. J. M., de Groot, F., & Rabelink, T. J. (1997) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1997.7069 · Cited by 281
Ohashi, Y., Kawashima, S., Hirata, K. I., Yamashita, T., Ishida, T., Inoue, N., Sakoda, T., Kurihara, H., Yazaki, Y., & Yokoyama, M. (1998) · Journal of Clinical Investigation · doi:10.1172/jci4394 · Cited by 277
Vascular endothelial dysfunction: does tetrahydrobiopterin play a role?
Katusic, Z. S. (2001) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.2001.281.3.h981 · Cited by 268
Shinozaki, K., Nishio, Y., Okamura, T., Yoshida, Y., Maegawa, H., Kojima, H., Masada, M., Toda, N., Kikkawa, R., & Kashiwagi, A. (2000) · Circulation Research · doi:10.1161/01.res.87.7.566 · Cited by 242
Leopold, J. A., Zhang, Y.-Y., Scribner, A. W., Stanton, R. C., & Loscalzo, J. (2003) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000056744.26901.ba · Cited by 218
Soriano, F. G., Pacher, P., Mabley, J., Liaudet, L., & Szabó, C. (2001) · Circulation Research · doi:10.1161/hh2001.097797 · Cited by 190
Meininger, C. J., MARINOS, R. S., Hatakeyama, K., Martı́nez–Zaguilán, R., Rojas, J. D., Kelly, K. A., & Wu, G. (2000) · Biochemical Journal · doi:10.1042/0264-6021:3490353 · Cited by 189
Tzeng, E., Billiar, T. R., Robbins, P. D., Loftus, M., & Stuehr, D. J. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.25.11771 · Cited by 174
Tetrahydrobiopterin and endothelial nitric oxide synthase activity
Cosentino, F. (1999) · Cardiovascular Research · doi:10.1016/s0008-6363(99)00134-0 · Cited by 172
Vasquez-Vivar, J. M., Duquaine, D. C., Whitsett, J., Kalyanaraman, B., & Rajagopalan, S. (2002) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000029122.79665.d9 · Cited by 130
Vásquez-Vivar, J., Whitsett, J., Martásek, P., Hogg, N., & Kalyanaraman, B. (2001) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(01)00680-3 · Cited by 112 · cited 1×
“Indeed, both superoxide and peroxynitrite can oxidize BH4 under physiological conditions (14, 21, 32).”
BackgroundCai, S. (2002) · Cardiovascular Research · doi:10.1016/s0008-6363(02)00460-1 · Cited by 105
Self-citationMultiple mRNA forms of human GTP cyclohydrolase I
Togari, A., Ichinose, H., Matsumoto, S., Fujita, K., & Nagatsu, T. (1992) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(05)81501-3 · Cited by 94
Purification and Cloning of the GTP Cyclohydrolase I Feedback Regulatory Protein, GFRP
Milstien, S., Jaffe, H., Kowlessur, D., & Bonner, T. I. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.33.19743 · Cited by 89
Li, J., Mullen, A. M., & Shah, A. M. (2001) · Journal of Molecular and Cellular Cardiology · doi:10.1006/jmcc.2001.1372 · Cited by 54
Sepiapterin Treatment in Atherosclerosis
Tarpey, M. M. (2002) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000038144.37823.bf · Cited by 28
Cited by
Roles of vascular oxidative stress and nitric oxide in the pathogenesis of atherosclerosis
Förstermann, U., Xia, N., & Li, H. (2017) · Circulation Research · doi:10.1161/circresaha.116.309326 · Cited by 1,519
GTP Cyclohydrolase 1/Tetrahydrobiopterin Counteract Ferroptosis through Lipid Remodeling
Kraft, V. A. N., Bezjian, C. T., Pfeiffer, S., Ringelstetter, L., Müller, C., Zandkarimi, F., Merl-Pham, J., Bao, X., Anastasov, N., Kössl, J., et al. (2020) · ACS Central Science · doi:10.1021/acscentsci.9b01063 · Cited by 1,298
Endothelial dysfunction and vascular disease - a 30th anniversary update
Vanhoutte, P. M., Shimokawa, H., Feletou, M., & Tang, E. H. C. (2017) · Acta Physiologica · doi:10.1111/apha.12646 · Cited by 937
“…NO-dependent dilatations in diabetes include: (i) reduced BH4 bioavailability and eNOS uncoupling (Guzik et al. 2002, Pannirselvam et al. 2002, Alp et al. 2003, Cai et al. 2005); (ii) increased activity of arginase, likely resulting from an augmented presence/activity of Rho-kinase (Ming et…”
BackgroundEndothelial dysfunction and vascular disease
Vanhoutte, P. M., Shimokawa, H., Tang, E. H. C., & Feletou, M. (2009) · Acta Physiologica · doi:10.1111/j.1748-1716.2009.01964.x · Cited by 806
Nitric oxide signalling in cardiovascular health and disease
Farah, C., Michel, L. Y. M., & Balligand, J.-L. (2018) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2017.224 · Cited by 779
Metadata
- Authors
- Alp, N. J., Mussa, S., Khoo, J., Cai, S., Guzik, T., Jefferson, A., Goh, N., Rockett, K. A., & Channon, K. M.
- Venue
- Journal of Clinical Investigation
- Published
- 2003-09-01
- Volume
- 112
- Issue
- 5
- Pages
- 725-735
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2169782569
- Cited by
- 321
- References
- 32
- FWCI
- 10.13
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.